文献速递中毒与环境急症重症综合管理与镇静镇痛

中国云南野生蘑菇中毒患者接受乙酰半胱氨酸治疗时类过敏反应的研究

Anaphylactoid reactions to acetylcysteine treatment in wild mushroom poisoning patients in Yunnan, China.
PubMed 文献 · Clin Toxicol (Phila) · 2025-06-04
一句话结论野生蘑菇中毒患者静脉使用乙酰半胱氨酸时类过敏反应风险显著高于其他适应证患者(OR 5.43,95%CI 1.63-18.13),女性及有过敏史为独立危险因素。

该回顾性队列研究纳入2023年1月1日至2024年8月31日期间接受静脉乙酰半胱氨酸治疗的患者110例,其中野生蘑菇中毒20例,其他适应证90例。主要结局为类过敏反应发生情况,蘑菇中毒组风险显著升高(OR 5.43;95%CI 1.63-18.13),症状通常轻微。女性(OR 3.49;95%CI 1.02-11.95)和过敏史(OR 3.82;95%CI 1.11-13.20)为独立危险因素,联合预测模型AUC为0.88(95%CI 0.81-0.95)。作者推测可能与蘑菇中微量元素与乙酰半胱氨酸结合有关。

要点

  • 野生蘑菇中毒患者静脉使用乙酰半胱氨酸时类过敏反应风险显著高于其他适应证患者(OR 5.43;95%CI 1.63-18.13)。
  • 类过敏反应症状通常轻微。
  • 女性(OR 3.49;95%CI 1.02-11.95)和有过敏史(OR 3.82;95%CI 1.11-13.20)是独立危险因素。
  • 联合上述因素的预测模型区分度良好(AUC 0.88;95%CI 0.81-0.95)。

适用人群与场景

  • 2023年1月1日至2024年8月31日期间在云南大学附属医院(云南省中毒治疗中心)接受静脉乙酰半胱氨酸治疗的患者。
  • 暴露组为野生蘑菇中毒患者,对照组为因其他适应证接受乙酰半胱氨酸治疗的患者。

研究设计与关键结果

  • 研究类型为回顾性队列研究,共纳入110例患者,其中野生蘑菇中毒20例,非蘑菇中毒90例。
  • 主要结局为类过敏反应发生:野生蘑菇中毒组风险显著高于对照组(OR 5.43;95%CI 1.63-18.13)。
  • 类过敏反应症状通常轻微。
  • 女性(OR 3.49;95%CI 1.02-11.95)和过敏史(OR 3.82;95%CI 1.11-13.20)为独立危险因素。
  • 联合危险因素的预测模型AUC为0.88(95%CI 0.81-0.95)。
  • 亚组分析涵盖性别、年龄、体重、剂量、过敏史、总胆红素、丙氨酸氨基转移酶、天冬氨酸氨基转移酶、γ-谷氨酰转移酶、碱性磷酸酶、凝血酶原时间及乙酰半胱氨酸最快输注速度。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,野生蘑菇中毒患者静脉使用乙酰半胱氨酸时可能面临更高的类过敏反应风险。
  • 作者推测,野生蘑菇中的微量元素在未充分烹饪时生物利用度更高,蓄积后与乙酰半胱氨酸结合形成引起类过敏反应的物质。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: The Affiliated Hospital of Yunnan University, serving as the Poisoning Treatment Center of Yunnan Province, receives nearly all patients with wild mushroom poisoning requiring emergency treatment. We anecdotally observed a higher incidence of anaphylactoid reactions in patients admitted to our hospital for wild mushroom poisoning who received acetylcysteine.

METHODS: This retrospective cohort study was conducted from January 1, 2023, to August 31, 2024. The study included patients who received intravenous acetylcysteine. Patients were divided into two groups: the exposure group comprised patients with wild mushroom poisoning, while the comparison group included patients receiving acetylcysteine for other indications. The primary outcome measure was the occurrence of anaphylactoid reactions. Subgroup analyses were performed for sex, age, weight, dose, history of allergies, total bilirubin concentration, alanine aminotransferase activity, aspartate aminotransferase activity, gamma-glutamyl transferase activity, alkaline phosphatase activity, prothrombin time, and the fastest rate of acetylcysteine infusion.

RESULTS: One-hundred and ten patients were included: 20 with wild mushroom poisoning and 90 without. Patients with wild mushroom poisoning exhibited a significantly higher risk of anaphylactoid reactions (OR: 5.43; 95% CI: 1.63-18.13). Symptoms of anaphylactoid reactions were typically mild. Additionally, female gender (OR: 3.49; 95% CI: 1.02-11.95) and history of allergies (OR: 3.82; 95% CI: 1.11-13.20) were identified as independent risk factors. A predictive model combining these factors showed good performance (area under the receiver operating characteristic curve 0.88; 95% CI: 0.81-0.95).

DISCUSSION: A possible reason for this phenomenon is the presence of various trace mineral elements in wild mushrooms, which exhibit higher bioavailability when mushrooms are not cooked fully. Accumulated mineral elements in wild mushroom poisoning patients bind with acetylcysteine, forming substances that cause anaphylactoid reactions.

CONCLUSIONS: Patients with wild mushroom poisoning appear to be at an increased risk of anaphylactoid reactions during intravenous acetylcysteine administration compared to those who did not consume wild mushrooms.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Lei TY, Chuan LF, Xing XQ, et al. Anaphylactoid reactions to acetylcysteine treatment in wild mushroom poisoning patients in Yunnan, China. Clin Toxicol (Phila). 2025. PMID: 40462751. doi:10.1080/15563650.2025.2509723

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。